Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.
Gastroenterology. 2020 Feb;158(3):537-549.e10. doi: 10.1053/j.gastro.2019.08.043. Epub 2019 Sep 4.
Gastroenterology. 2020.
PMID: 31493397
Free article.
Clinical Trial.
Efficacy and safety of mirikizumab (LY3074828) in the treatment of moderate-to-severe plaque psoriasis: results from a randomized phase II study.
Reich K, Rich P, Maari C, Bissonnette R, Leonardi C, Menter A, Igarashi A, Klekotka P, Patel D, Li J, Tuttle J, Morgan-Cox M, Edson-Heredia E, Friedrich S, Papp K; AMAF investigators.
Reich K, et al. Among authors: morgan cox m.
Br J Dermatol. 2019 Jul;181(1):88-95. doi: 10.1111/bjd.17628. Epub 2019 Apr 17.
Br J Dermatol. 2019.
PMID: 30734266
Clinical Trial.
Item in Clipboard
Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.
Isenberg DA, Petri M, Kalunian K, Tanaka Y, Urowitz MB, Hoffman RW, Morgan-Cox M, Iikuni N, Silk M, Wallace DJ.
Isenberg DA, et al. Among authors: morgan cox m.
Ann Rheum Dis. 2016 Feb;75(2):323-31. doi: 10.1136/annrheumdis-2015-207653. Epub 2015 Sep 3.
Ann Rheum Dis. 2016.
PMID: 26338095
Clinical Trial.
Item in Clipboard
Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.
Merrill JT, van Vollenhoven RF, Buyon JP, Furie RA, Stohl W, Morgan-Cox M, Dickson C, Anderson PW, Lee C, Berclaz PY, Dörner T.
Merrill JT, et al. Among authors: morgan cox m.
Ann Rheum Dis. 2016 Feb;75(2):332-40. doi: 10.1136/annrheumdis-2015-207654. Epub 2015 Aug 20.
Ann Rheum Dis. 2016.
PMID: 26293163
Clinical Trial.
Item in Clipboard
Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index.
Kalunian KC, Urowitz MB, Isenberg D, Merrill JT, Petri M, Furie RA, Morgan-Cox MA, Taha R, Watts S, Silk M, Linnik MD.
Kalunian KC, et al. Among authors: morgan cox ma.
Rheumatology (Oxford). 2018 Jan 1;57(1):125-133. doi: 10.1093/rheumatology/kex368.
Rheumatology (Oxford). 2018.
PMID: 29045736
Free article.
Item in Clipboard
Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials.
Blauvelt A, Thyssen JP, Guttman-Yassky E, Bieber T, Serra-Baldrich E, Simpson E, Rosmarin D, Elmaraghy H, Meskimen E, Natalie CR, Liu Z, Xu C, Pierce E, Morgan-Cox M, Garcia Gil E, Silverberg JI.
Blauvelt A, et al. Among authors: morgan cox m.
Br J Dermatol. 2023 May 24;188(6):740-748. doi: 10.1093/bjd/ljad022.
Br J Dermatol. 2023.
PMID: 36994947
Clinical Trial.
Item in Clipboard
Elevated body mass index in Texas Head Start children: a result of heredity and economics.
Piziak V, Morgan-Cox M, Tubbs J, Rajab MH.
Piziak V, et al. Among authors: morgan cox m.
South Med J. 2010 Dec;103(12):1219-22. doi: 10.1097/SMJ.0b013e3181faeb4d.
South Med J. 2010.
PMID: 20978460
Item in Clipboard
Cite
Cite